OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T Cells in Systemic Sclerosis
C. Frantz, Cédric Auffray, Jérôme Avouac, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial
Dinesh Khanna, Cathie Spino, Sindhu R. Johnson, et al.
Arthritis & Rheumatology (2019) Vol. 72, Iss. 1, pp. 125-136
Open Access | Times Cited: 195

Treg cells in autoimmunity: from identification to Treg-based therapies
Lisa Göschl, Clemens Scheinecker, Michael Bonelli
Seminars in Immunopathology (2019) Vol. 41, Iss. 3, pp. 301-314
Closed Access | Times Cited: 164

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Dinesh Khanna, Donald P. Tashkin, Christopher P. Denton, et al.
American Journal of Respiratory and Critical Care Medicine (2019) Vol. 201, Iss. 6, pp. 650-660
Open Access | Times Cited: 150

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
T. K. Goswami, Mithilesh Singh, Manish Dhawan, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 128

Pathophysiology of systemic sclerosis (scleroderma)
Ann-Helen Rosendahl, Katrin Schönborn, Thomas Krieg
The Kaohsiung Journal of Medical Sciences (2022) Vol. 38, Iss. 3, pp. 187-195
Open Access | Times Cited: 82

Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair
Ian C. Boothby, Jarish N. Cohen, Michael D. Rosenblum
Science Immunology (2020) Vol. 5, Iss. 47
Open Access | Times Cited: 126

Interleukin-2 and regulatory T cells in rheumatic diseases
Antonios G.A. Kolios, George C. Tsokos, David Klatzmann
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 12, pp. 749-766
Closed Access | Times Cited: 85

Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis
Dan Fang, Beidi Chen, Alain Lescoat, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 12, pp. 683-693
Closed Access | Times Cited: 51

T cell abnormalities in systemic sclerosis
Wei Jin, Zheng Yan, Ping Zhu
Autoimmunity Reviews (2022) Vol. 21, Iss. 11, pp. 103185-103185
Closed Access | Times Cited: 43

Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases
Nathalie Burg, Jane E. Salmon, Timothy Hla
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 6, pp. 335-351
Open Access | Times Cited: 40

IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Valentina Lykhopiy, Vanshika Malviya, Stéphanie Humblet‐Baron, et al.
Genes and Immunity (2023) Vol. 24, Iss. 5, pp. 248-262
Open Access | Times Cited: 30

Common Variable Immunodeficiency Associated With Noninfectious Pulmonary Complications and Its Treatment: Beyond Immunoglobulin Therapy
Austin Parsons, Domingo Franco‐Palacios, Bryan Kelly, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Autoreactive T-Lymphocytes in Inflammatory Skin Diseases
Wolf‐­Henning Boehncke, Nicolò Costantino Brembilla
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 62

Is There a Place for Chimeric Antigen Receptor–T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Cindy Orvain, Morgane Boulch, Philippe Bousso, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 11, pp. 1954-1965
Open Access | Times Cited: 48

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
Aurélien Chepy, Louisa Bourel, Vincent Koether, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30

Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs
Cristina M. Padilla, Eleanor Valenzi, Tracy Tabib, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 837-845
Closed Access | Times Cited: 18

Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases
Ye Shu, Qinghua Hu, Hai Long, et al.
Clinical Reviews in Allergy & Immunology (2016) Vol. 52, Iss. 2, pp. 260-272
Closed Access | Times Cited: 53

The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
Wen Tian, Shirley Y. Jiang, Xinguo Jiang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40

Regulatory T cell heterogeneity and therapy in autoimmune diseases
Rui Zhang, Jinlin Miao, Ping Zhu
Autoimmunity Reviews (2020) Vol. 20, Iss. 5, pp. 102715-102715
Closed Access | Times Cited: 39

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
Devis Benfaremo, Silvia Svegliati, Chiara Paolini, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 163-163
Open Access | Times Cited: 25

Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management
Elena De Zorzi, Paolo Spagnolo, Elisabetta Cocconcelli, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 63, Iss. 3, pp. 472-489
Open Access | Times Cited: 25

Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1–phase 2a study
F. Barde, Roberta Lorenzon, Éric Vicaut, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003500-e003500
Open Access | Times Cited: 5

The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis
Peiyan Zhang, Jiawei Wang, Jinlin Miao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Page 1 - Next Page

Scroll to top